FDA Warning Letter — CP Pharmaceuticals Limited
The FDA took a Warning Letter action against CP Pharmaceuticals Limited on November 16, 2016 (Wrexham, United Kingdom). The action was issued by CDER and concerns drugs products. This facility has 4 recent FDA inspections on record.
Action Details
- Facility
- CP Pharmaceuticals Limited
- Date
- November 16, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Wrexham (United Kingdom)